Atle Fund Management AB
Clone Performance
Aug 2023–Aug 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends; a captured split can shorten the simulated window. It tracks 100% of reported value on average across 12 quarters. Past performance does not predict future results.
Portfolio Concentration
39 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $371,705,195 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | +1,006,762 | 1,048,593 | $2,296,418 | |
| PYXS | Pyxis Oncology, Inc. | +769,423 | 966,459 | $2,909,041 | |
| TNGX | Tango Therapeutics, Inc. | +168,642 | 198,557 | $6,206,891 | |
| MRK | Merck & Co., Inc. | +155,504 | 189,357 | $24,332,374 | |
| NAMS | NewAmsterdam Pharma Co N.V. | +154,052 | 248,848 | $8,433,458 | |
| CVS | CVS HEALTH Corp | +122,329 | 146,102 | $15,114,251 | |
| IONS | Ionis Pharmaceuticals Inc | +109,258 | 137,131 | $10,873,116 | |
| BSX | Boston Scientific Corp | +105,949 | 146,381 | $6,247,541 | |
| IDYA | IDEAYA Biosciences, Inc. | +63,345 | 94,478 | $3,521,195 | |
| IRTC | iRhythm Holdings, Inc. | +31,780 | 54,102 | $6,435,432 | |
| ABVX | Abivax S.A. | +26,580 | 58,170 | $7,751,734 | |
| BBIO | BridgeBio Pharma, Inc. | +13,344 | 124,707 | $9,288,177 | |
| COR | Cencora, Inc. | +7,656 | 31,126 | $8,808,035 | |
| INCY | Incyte Corp | +6,157 | 56,953 | $6,456,192 | |
| TMO | Thermo Fisher Scientific Inc. | +4,873 | 27,859 | $13,967,388 | |
| SYK | Stryker Corp | +3,448 | 30,283 | $9,534,299 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | −1,023,977 | 145,657 | $4,324,556 | |
| RVMD | Revolution Medicines, Inc. | −544,168 | 73,077 | $13,685,860 | |
| DXCM | Dexcom Inc | −512,486 | 71,846 | $4,838,828 | |
| CELC | Celcuity Inc. | −107,983 | 33,313 | $3,485,206 | |
| MIRM | Mirum Pharmaceuticals, Inc. | −94,961 | 100,807 | $11,801,475 | |
| CAH | Cardinal Health Inc | −85,052 | 23,630 | $5,613,542 | |
| IRON | Disc Medicine, Inc. | −63,573 | 43,682 | $3,194,901 | |
| ISRG | Intuitive Surgical Inc | −46,195 | 24,656 | $9,805,198 | |
| ABBV | AbbVie Inc. | −43,856 | 64,325 | $16,186,743 | |
| INSM | INSMED Inc | −39,060 | 58,378 | $6,224,262 | |
| ALKS | Alkermes plc. | −29,144 | 213,329 | $11,177,372 | |
| NBIX | Neurocrine Biosciences Inc | −16,787 | 72,898 | $12,286,228 | |
| KRYS | Krystal Biotech, Inc. | −13,560 | 24,019 | $8,927,141 | |
| LLY | ELI LILLY & Co | −9,901 | 29,821 | $35,768,205 | |
| JNJ | Johnson & Johnson | −6,952 | 85,425 | $21,695,387 | |
| ONC | BeOne Medicines Ltd. | −6,537 | 35,180 | $10,025,244 | |
| SYRE | Spyre Therapeutics, Inc. | −5,705 | 57,030 | $5,063,123 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | −3,853 | 19,131 | $9,502,941 | |
| EW | Edwards Lifesciences Corp | −3,288 | 103,230 | $9,338,185 | |
| GILD | Gilead Sciences, Inc. | −1,825 | 46,142 | $5,829,580 | |
| No positions match the current search. | |||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 29,821 | $35,768,205 | 9.62% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Added | 189,357 | $24,332,374 | 6.55% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 85,425 | $21,695,387 | 5.84% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Reduced | 64,325 | $16,186,743 | 4.35% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Added | 146,102 | $15,114,251 | 4.07% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 27,859 | $13,967,388 | 3.76% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 73,077 | $13,685,860 | 3.68% | |
| BIIB |
Biogen Inc.
Healthcare
|
NEW | 62,781 | $13,564,462 | 3.65% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 72,898 | $12,286,228 | 3.31% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 100,807 | $11,801,475 | 3.17% | |
| ALKS |
Alkermes plc.
Healthcare
|
Reduced | 213,329 | $11,177,372 | 3.01% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 137,131 | $10,873,116 | 2.93% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
Reduced | 35,180 | $10,025,244 | 2.70% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 24,656 | $9,805,198 | 2.64% | |
| SYK |
Stryker Corp
Healthcare
|
Added | 30,283 | $9,534,299 | 2.57% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Reduced | 19,131 | $9,502,941 | 2.56% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 103,230 | $9,338,185 | 2.51% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 124,707 | $9,288,177 | 2.50% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 24,019 | $8,927,141 | 2.40% | |
| COR |
Cencora, Inc.
Healthcare
|
Added | 31,126 | $8,808,035 | 2.37% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Added | 248,848 | $8,433,458 | 2.27% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 58,170 | $7,751,734 | 2.09% | |
| INCY |
Incyte Corp
Healthcare
|
Added | 56,953 | $6,456,192 | 1.74% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 54,102 | $6,435,432 | 1.73% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 146,381 | $6,247,541 | 1.68% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 58,378 | $6,224,262 | 1.67% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 198,557 | $6,206,891 | 1.67% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Reduced | 46,142 | $5,829,580 | 1.57% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Reduced | 23,630 | $5,613,542 | 1.51% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 54,886 | $5,223,500 | 1.41% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 57,030 | $5,063,123 | 1.36% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 71,846 | $4,838,828 | 1.30% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Reduced | 145,657 | $4,324,556 | 1.16% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Added | 94,478 | $3,521,195 | 0.95% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 33,313 | $3,485,206 | 0.94% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 43,682 | $3,194,901 | 0.86% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
Added | 966,459 | $2,909,041 | 0.78% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Added | 1,048,593 | $2,296,418 | 0.62% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
NEW | 88,556 | $1,967,714 | 0.53% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.